mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy - Weiler, Markus; Deimling, Andreas von; Winkler, Frank; Platten, Michael; Wick, Wolfgang; Blaes, Jonas; Sahm, Felix; Bunse, Lukas; Osswald, Matthias; Rübmann, Petra; Pfenning, Philipp-Niclas; Abdollahi, Amir; et al. (Proceedings of the National Academy of Sciences of the United States of America, 2014)